Moderna Files for FDA Approval of Its COVID Vaccine in Teens
On Thursday, Moderna (NASDAQ: MRNA) announced it has filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents from 12 to 18. If the agency gives Moderna a green light, parents will have another vaccine option beyond Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) vaccine, which was approved for ages 12 to 18 in May.
Image source: Getty Images.
The coronavirus can be spread easily, and so far, over 174 million cases and 3.7 million deaths have been attributed to the disease worldwide.
Source Fool.com
